Search company, investor...

Predict your next investment

Venture Capital
lightstonevc.com

Investments

93

Portfolio Exits

11

Funds

4

Partners & Customers

1

About Lightstone Ventures

Lightstone Ventures was founded in 2012 by the General Partners and other key members of the life science teams of Advanced Technology Ventures (ATV) and Morgenthaler. The firm was formed to capture the upside of investing in breakthrough life science companies during a time of unique opportunity in the space. Lightstone invests in early stage therapeutics, with later stage investments pursued selectively.

Headquarters Location

2884 Sand Hill Road Suite 121

Menlo Park, California, 94025,

United States

650-388-3676

Are you an investor?
Submit your portfolio details now to be considered in our investor rankings.

Expert Collections containing Lightstone Ventures

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Find Lightstone Ventures in 1 Expert Collection, including Vitamin & Supplement Startups.

V

Vitamin & Supplement Startups

237 items

Latest Lightstone Ventures News

SG’s biotech deal flow and ecosystem have come a long way: Lightstone Ventures

Oct 20, 2023

20 October, 2023 Singapore’s fledgling biotech ecosystem has large and very unique challenges to tackle but has come a long way since its early years, shared Christina Isacson, partner at US-based Lightstone Ventures. Subscribe now to enjoy unlimited access at just $52. Premium coverage on private equity, venture capital, and startups in Asia. Exclusive scoops from our reporters in nine key markets. In-depth interviews with industry leaders shaping the ecosystem.

Lightstone Ventures Investments

93 Investments

Lightstone Ventures has made 93 investments. Their latest investment was in Nimbus Therapeutics as part of their Series G on September 9, 2023.

CBI Logo

Lightstone Ventures Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

9/6/2023

Series G

Nimbus Therapeutics

$210M

No

2

9/1/2023

Series B

Tallac Therapeutics

No

6/22/2023

Series A

Tagworks Pharmaceuticals

$65M

Yes

5

5/25/2023

Series A

Subscribe to see more

$99M

Subscribe to see more

10

4/19/2023

Series G - II

Subscribe to see more

$99M

Subscribe to see more

10

Date

9/6/2023

9/1/2023

6/22/2023

5/25/2023

4/19/2023

Round

Series G

Series B

Series A

Series A

Series G - II

Company

Nimbus Therapeutics

Tallac Therapeutics

Tagworks Pharmaceuticals

Subscribe to see more

Subscribe to see more

Amount

$210M

$65M

$99M

$99M

New?

No

No

Yes

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

2

5

10

10

Lightstone Ventures Portfolio Exits

11 Portfolio Exits

Lightstone Ventures has 11 portfolio exits. Their latest portfolio exit was Relievant Medsystems on September 19, 2023.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

9/19/2023

Acquired

$99M

6

1/7/2022

IPO

$99M

Public

7

6/18/2021

IPO

$99M

Public

1

2/8/2021

Reverse Merger

Subscribe to see more

$99M

Subscribe to see more

10

1/14/2021

Acquired

Subscribe to see more

$99M

Subscribe to see more

10

Date

9/19/2023

1/7/2022

6/18/2021

2/8/2021

1/14/2021

Exit

Acquired

IPO

IPO

Reverse Merger

Acquired

Companies

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

$99M

Acquirer

Public

Public

Subscribe to see more

Subscribe to see more

Sources

6

7

1

10

10

Lightstone Ventures Fund History

4 Fund Histories

Lightstone Ventures has 4 funds, including Lightstone Ventures III.

Closing Date

Fund

Fund Type

Status

Amount

Sources

9/14/2021

Lightstone Ventures III

$375M

2

9/20/2017

Lightstone Ventures II

Subscribe to see more

Subscribe to see more

$99M

10

1/26/2016

Lightstone Singapore

Subscribe to see more

Subscribe to see more

$99M

10

5/1/2014

Lightstone Ventures

$99M

10

Closing Date

9/14/2021

9/20/2017

1/26/2016

5/1/2014

Fund

Lightstone Ventures III

Lightstone Ventures II

Lightstone Singapore

Lightstone Ventures

Fund Type

Subscribe to see more

Subscribe to see more

Status

Subscribe to see more

Subscribe to see more

Amount

$375M

$99M

$99M

$99M

Sources

2

10

10

10

Lightstone Ventures Partners & Customers

1 Partners and customers

Lightstone Ventures has 1 strategic partners and customers. Lightstone Ventures recently partnered with Ireland Strategic Investment Fund on July 7, 2020.

Date

Type

Business Partner

Country

News Snippet

Sources

7/1/2020

Partner

Ireland

State-backed ALX Oncology lines up a $100m IPO

The Ireland Strategic Investment Fund has a minority interest in the company through its partnership with Lightstone Ventures .

1

Date

7/1/2020

Type

Partner

Business Partner

Country

Ireland

News Snippet

State-backed ALX Oncology lines up a $100m IPO

The Ireland Strategic Investment Fund has a minority interest in the company through its partnership with Lightstone Ventures .

Sources

1

Lightstone Ventures Team

5 Team Members

Lightstone Ventures has 5 team members, including current Managing General Partner, Michael A. Carusi.

Name

Work History

Title

Status

Michael A. Carusi

Managing General Partner

Current

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Name

Michael A. Carusi

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Work History

Title

Managing General Partner

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Current

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.